Pretoria, Feb 9 (Prensa Latina) The National Education, Health and Allied Workers’ Union (NEHAWU) in South Africa advocated for assessing the use in the country of Covid-19 vaccine candidates developed in Cuba and Russia.
The request to the government comes after some scientific studies suggested that the AstraZeneca vaccine bought by South Africa has poorer efficacy against Covid-19 in its mild and moderate forms, caused by the 501Y.V2 viral variant emerged in the country.
In a statement, NEHAWU affirms that the government ‘should consider (the use of) the two coronavirus vaccine candidates, Soberana 1 and Soberana 2, developed by Cuba’s Finlay Institute of Vaccines.’
The clinical trials of one of them, NEHAWU adds, have made progress to demonstrate at this time ‘the optimal level of antigen concentration to protect people who have previously been infected’ with Covid-19.
In the text, NEHAWU also urges that the government includes Russia’s Sputnik V vaccine among the options to consider in South Africa. Its manufacturer, from Moscow’s Gamalei Research Center, have published impressive results of the clinical trials’ Phase III in The Lancet Journal last week.
South Africa aims to vaccinate 67 percent of its population against Covid-19 to achieve herd immunity, which in turn would protect 100 percent of South Africans from the disease.